OptiBiotix Health PLC
LSE:OPTI

Watchlist Manager
OptiBiotix Health PLC Logo
OptiBiotix Health PLC
LSE:OPTI
Watchlist
Price: 6.75 GBX Market Closed
Market Cap: 7m GBX

Relative Value

OPTI doesn't have a meaningful market cap.

The Relative Value of one OPTI stock under the Base Case scenario is hidden GBX. Compared to the current market price of 6.75 GBX, OptiBiotix Health PLC is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

OPTI Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
96
vs Industry
26
Median 3Y
20.6
Median 5Y
20.3
Industry
8
vs History
vs Industry
11
Median 3Y
-8.1
Median 5Y
-1.8
Industry
23.5
vs History
vs Industry
Median 3Y
-10
Median 5Y
-12.8
Industry
21.9
vs History
vs Industry
Median 3Y
-9.5
Median 5Y
-11.7
Industry
24.3
vs History
82
vs Industry
37
Median 3Y
1.9
Median 5Y
1.9
Industry
3.2
vs History
96
vs Industry
23
Median 3Y
19.7
Median 5Y
19.4
Industry
8.1
vs History
96
vs Industry
13
Median 3Y
49.9
Median 5Y
42.9
Industry
10.1
vs History
vs Industry
14
Median 3Y
-4.9
Median 5Y
-7.6
Industry
5.9
vs History
vs Industry
12
Median 3Y
-4.4
Median 5Y
-6.8
Industry
6.2
vs History
vs Industry
Median 3Y
-9.6
Median 5Y
-11.7
Industry
7.7
vs History
vs Industry
Median 3Y
-8.7
Median 5Y
-11.2
Industry
6.3
vs History
82
vs Industry
43
Median 3Y
1.9
Median 5Y
1.9
Industry
5.6

Multiples Across Competitors

OPTI Competitors Multiples
OptiBiotix Health PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
OptiBiotix Health PLC
LSE:OPTI
7m GBP 6.1 -36.5 -2.3 -2.2
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 766 261.7 -160 486 -194 881.2 -192 657.4
US
Abbvie Inc
NYSE:ABBV
405.3B USD 6.8 172.6 16.7 23.7
US
Amgen Inc
NASDAQ:AMGN
176.3B USD 4.9 25.2 18.2 18.2
US
Gilead Sciences Inc
NASDAQ:GILD
151B USD 5.2 18.6 12.5 12.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
114.8B USD 9.8 31.2 22.9 23.9
US
Epizyme Inc
F:EPE
94.1B EUR 2 086.4 -532.4 -579.7 -564.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.7B USD 5.7 17.9 17 19.3
AU
CSL Ltd
ASX:CSL
83.3B AUD 3.6 18.6 12.5 15.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.7B USD 16.4 1 210.6 163.2 198
NL
argenx SE
XBRU:ARGX
44.3B EUR 14.4 33.9 58.5 60.1
P/E Multiple
Earnings Growth PEG
UK
OptiBiotix Health PLC
LSE:OPTI
Average P/E: 191.1
Negative Multiple: -36.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 486 N/A N/A
US
Abbvie Inc
NYSE:ABBV
172.6
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.2
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.6
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.2
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -532.4 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.9
10%
1.8
AU
CSL Ltd
ASX:CSL
18.6
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 210.6
N/A N/A
NL
argenx SE
XBRU:ARGX
33.9
40%
0.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
OptiBiotix Health PLC
LSE:OPTI
Average EV/EBITDA: 40.2
Negative Multiple: -2.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 881.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.7
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.2
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.9
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -579.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17
11%
1.5
AU
CSL Ltd
ASX:CSL
12.5
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
163.2
N/A N/A
NL
argenx SE
XBRU:ARGX
58.5
810%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
UK
OptiBiotix Health PLC
LSE:OPTI
Average EV/EBIT: 46.4
Negative Multiple: -2.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 657.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.7
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.2
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.9
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -564.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.3
13%
1.5
AU
CSL Ltd
ASX:CSL
15.7
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
198
N/A N/A
NL
argenx SE
XBRU:ARGX
60.1
N/A N/A